Table 2.
Knockout of β4 gene reduced somatic signs in morphine-treated mice
Individual somatic signs | β4 WT SAL | β4 KO SAL | β4 WT MOR | β4 KO MOR |
---|---|---|---|---|
Paw tremors | 4.5 ± 0.8 | 7.2 ± 0.5 | 22.8 ± 5.1* | 11.9 ± 2.5# |
Head shakes | 2.8 ± 0.8 | 4.3 ± 0.5 | 25.5 ± 6.1* | 8.9 ± 2.0# |
Backing | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
Ptosis | 0 ± 0 | 0 ± 0 | 2.6 ± 0.7 | 1.3 ± 0.7 |
Jumping | 0.7 ± 0.3 | 0 ± 0 | 15.6 ± 7.2* | 14 ± 5.8* |
Body tremor | 0 ± 0 | 0 ± 0 | 6.9 ± 1.0* | 2.7 ± 0.6*# |
Occurrence of diarrhoea (% of mice) | 0 | 0 | 50 | 0 |
Mice were made dependent on morphine for 8 days. On day 9, mice were administered naloxone (2 mg·kg−1) before observing individual physical signs expressed as mean ± SEM and % occurrence of diarrhoea.
n = 8 mice per group.
P < 0.05 from saline group.
P < 0.05 from morphine WT group.
MOR, morphine; SAL, saline.